EUSA Finds Japanese Partner For Lead Product In Generics-turned-innovator Ohara

TOKYO - In-licensing firm EUSA Pharma established its first partnership in Japan, behind similar deals in South Korea and China, for its acute lymphoblastic leukemia treatment Erwinase (erwinia L-asparaginase)